You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Exercise Disclosure
Agarwal Arjun · SEC Form 4 · Filed Aug 14, 2026
Exercise
Calculated transaction value
$0
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$108.12
Aug 13, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 1,458 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000907654-26-000075
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$1.22M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 13, 2026 | $225.08K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 13, 2026 | $50.14K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 13, 2026 | $219.81K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 13, 2026 | $106.78K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 13, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA Current | Exercise | Aug 13, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 13, 2026 | $230.72K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 13, 2026 | $255.76K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 13, 2026 | $135.2K |